Skip to main content

BC Cancer – Surrey

If you are interested in more information about a particular trial, please talk with your treating physician first, and they may contact this centre for further information if necessary.

Tumour Group / Site Trial Title Opening Date

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy (ATHENA)

Feb 2019
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Of Atezolizumab (Anti-Pd-L1 Antibody) As Adjuvant Therapy After Definitive Local Therapy In Patients With High‑Risk Locally Advanced Squamous Cell Carcinoma Of The Head And Neck.  Protocol Wo40242
(IMvoke 010)
Dec 2018
GUAndrogen Suppression with Stereotactic Body or External Beam Radiation Therapy-A Phase II Randomized Trial for Intermediate and High Risk Prostate Cancer (ASSERT)June 2016
LungA Phase 3 Prospective Double Blind Placebo Controlled Randomized Study of Adjuvant Medi4736 in Completely Resected Non-Small Cell Lung Cancer (CCTG BR.31)Sept 2015
A Phase II Randomized Study of 
Pembrolizumab in Patients with Advanced Malignant Pleural 
Mesothelioma (CCTG IND.227)
Feb 2017
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Subjects with Extensive Stage Small Cell Lung Cancer (MERU M16-298 AbbVie)
Feb 2018
LymphomaBiology of Lymphoid Cancer (Lymphoid Study)Jan 2014

A Randomized Phase III Study of Duration of Anti-PD-1 Therapy in Metastatic Melanoma (STOP-GAP) CCTG ME.13

July 2017
Randomized, open label, multicenter study assessing the clinical benefit
 of isatuximab combined with carfilzomib (Kyprolis®) and dexamethasone
versus carfilzomib with dexamethasone in patients with relapsed and/or
refractory multiple myeloma previously treated with 1 to 3 prior lines (Sanofi IKEMA)

June 2018

 You can view a video on participating in clinical trials that was created by staff at BC Cancer's Fraser Valley Centre.

SOURCE: BC Cancer – Surrey ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © BC Cancer. All Rights Reserved.

    Copyright © 2019 Provincial Health Services Authority